Mazor Robotics Message Board


Sage Therapeutics Reports Topline Results from Pivotal Phase 3 MOUNTAIN Study of SAGE-217 in Major Depressive Disorder

22 hours ago

Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company developing novel therapies for people with debilitating brain disorders, today reported topline results from the pivotal Phase 3 MOUNTAIN Study evaluating the effect of SAGE-217 on depressive symptoms in adults with major depressive disorder (MDD). The MOUNTAIN Study did not meet its primary endpoint of a statistically significant reduction from baseline compared to placebo

​How many patient injury claims does Mazor Robotics have?

7 months ago

The reps plan the pedicle screw placements for the robot to position for the patient and surgeon. The surgeon drills as directed by the robot (rep). Mazor will never admit (be honest) on this. It’s SOP for the clinical reps. So many other issues with Mazor and the robot. Needs to be looked into.

Chris Sells Mazor

8 months ago

CLOWNS with a small Baby Clown following.

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting

23 hours ago

​GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences announced today that a variety of data, including results from completed Phase 3 trials of EPIDIOLEX (cannabidiol) oral solution CV, will be presented at the American Epilepsy Society (AES) Annual Meeting, December 6-10, in Baltimore

Cytokinetics Announces New Results Presented at the International Symposium on ALS/MND

24 hours ago

​Cytokinetics (Nasdaq: CYTK) today announced that new results were presented at the 30th International Symposium on ALS/MND in Perth, Australia, including additional analyses from FORTITUDE-ALS (Functional Outcomes in a Randomized Trial of Investigational Treatment with CK-2127107 to Understand Decline in Endpoints – in ALS), the Phase 2 clinical trial of reldesemtiv in patients with amyotrophic lateral sclerosis (ALS)

Is Medtronic going to buy Mazor?

1 year ago

Well, you were wrong. Both are still separate companies and why would Mazor allow a buyout when their stock has more than doubled in the last year?

Mazor X has actually sold quicker than any of Intuitive Surgical's systems and ended the year at 72 X installs compared to only 6 in 2016. Mazor holds all the cards and there's no question Medtronic helped them gain traction but still, why sell?


CEO Insider Trading Probe

2 years ago

Fair to assume this was all made up and bad reporting?

Predictive Oncology Confirms Indications of Interest for Skyline Medical Business

1 day ago

​MINNEAPOLIS, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has received indications of interest from several parties for the possible acquisition of its Skyline Medical division, which produces and sells the STREAMWAY System

Mazor Robotics Earnings $MZOR

2 years ago

CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (MZOR), a pioneer and a leader in the field of surgical guidance systems, reported record second quarter revenue of $15.5 million. As previously announced, the Company received purchase orders for 19 systems in the 2017 second quarter and ended the quarter with a backlog of 14 systems.

"Our Q2 performance is highlighted by record quarterly revenue and a year-over-year increase of 87%, which reflects the market's excitement for Mazor X and th…

Mazor Robotics Reports Record Second Quarter 2017 Revenue Increased 87% to $15.5 Million

Mazor Robotics is a innovator in spine surgery. Mazor X surgical system, Renaissance Surgical Guidance System

Clinical Sales Specialist

2 years ago

Is Medtronic ever concerned with Mazor Robotics having 25 yr old reps with no prior OR or Spine experience Fully Plan and Run a Robotic Spine Procedure?


Teladoc Health Expands Services with Personalized Nutrition Counseling

2 days ago

Teladoc Health, Inc. (NYSE: TDOC) today announced the continued expansion of its clinical services with the addition of Teladoc Nutrition, personalized nutrition counseling combined with specialized care from a registered dietitian. Providing virtual access to nutrition services as part of the Teladoc Health comprehensive continuum of care

Loading...